Franzanne Vreeland
Medical Practice in Martinsville, NJ
License number
New Jersey 25MA05898000
Issued Date
Jan 22, 1993
Expiration Date
Jun 30, 2003
Category
Medical Examiners
Type
Medical Doctor
Address
Address
Martinsville, NJ
Professional information
Antitumor Therapy Comprising Distamycin Derivatives
US Patent:
6576612, Jun 10, 2003
Filed:
Oct 2, 2000
Appl. No.:
09/676770
Inventors:
Camilla Fowst - Milan, IT
Franzanne Vreeland - Martinsville NJ
Maria Cristina Rosa Geroni - Milan, IT
Franzanne Vreeland - Martinsville NJ
Maria Cristina Rosa Geroni - Milan, IT
Assignee:
Pharmacia Italia S.p.A. - Milan
Pharmacia Upjohn Company - Kalamazoo MI
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
A61K 3140
US Classification:
514 18, 514428, 514422, 514408, 544333, 548524, 548518, 5483147
Abstract:
The present invention relates to an administration schedule comprising the intravenous administration of a -halogen-acryloyl distamycin derivative of formula (I) wherein R is a bromine or chlorine atom; or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.
Method For Predicting The Sensitivity To Chemotherapy
US Patent:
6969592, Nov 29, 2005
Filed:
Sep 26, 2001
Appl. No.:
09/962611
Inventors:
Camilla Fowst - Milan, IT
Maria Christina Rosa Geroni - Milan, IT
Jennifer Margaret Tursi - Milan, IT
Franzanne Vreeland - Martinsville NJ, US
Maria Christina Rosa Geroni - Milan, IT
Jennifer Margaret Tursi - Milan, IT
Franzanne Vreeland - Martinsville NJ, US
Assignee:
Pharmacia Italia S.p.A. - Milan
Pharmacia & Upjohn Company LLC - Kalamazoo MI
Pharmacia & Upjohn Company LLC - Kalamazoo MI
International Classification:
C12Q001/48
US Classification:
435 15, 435193
Abstract:
The present invention relates to the field of cancer treatment and, more particularly, it relates to a method for predicting the sensitivity towards chemotherapy of a patient, by measuring glutathione (GSH) blood levels of the said patient undergoing chemotherapeutic treatment.
Antitumor Therapy Comprising Distamycin Derivatives
US Patent:
7399748, Jul 15, 2008
Filed:
Sep 21, 2001
Appl. No.:
10/381272
Inventors:
Camilla Fowst - Milan, IT
Franzanne Vreeland - Martinsville NJ, US
Maria Cristina Rosa Geroni - Milan, IT
Franzanne Vreeland - Martinsville NJ, US
Maria Cristina Rosa Geroni - Milan, IT
Assignee:
Nerviano Medical Sciences S.r.l. - Milan
International Classification:
A61K 31/40, C07D 207/34
US Classification:
514 18, 514428, 514422, 514408, 544333, 548524, 548518, 5483147
Abstract:
The present invention relates to an administration schedule comprising the intravenous administration of a α-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.